PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
19.27%
Revenue growth below 50% of CSIQ's 85.08%. Michael Burry would check for competitive disadvantage risks.
20.98%
Cost growth less than half of CSIQ's 81.69%. David Dodd would verify if cost advantage is structural.
12.71%
Gross profit growth below 50% of CSIQ's 105.12%. Michael Burry would check for structural issues.
-5.50%
Margin decline while CSIQ shows 10.83% expansion. Joel Greenblatt would examine competitive position.
47.80%
R&D growth 1.25-1.5x CSIQ's 35.92%. Martin Whitman would scrutinize investment rationale.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while CSIQ shows 53.71% growth. Joel Greenblatt would examine efficiency.
22.09%
Operating expenses growth less than half of CSIQ's 54.15%. David Dodd would verify sustainability.
21.23%
Total costs growth less than half of CSIQ's 78.01%. David Dodd would verify sustainability.
27.90%
Similar interest expense growth to CSIQ's 28.80%. Walter Schloss would investigate norms.
159.91%
D&A change of 159.91% while CSIQ maintains D&A. Bruce Berkowitz would investigate efficiency.
-185.68%
EBITDA decline while CSIQ shows 111.86% growth. Joel Greenblatt would examine position.
-139.53%
EBITDA margin decline while CSIQ shows 14.47% growth. Joel Greenblatt would examine position.
-90.19%
Operating income decline while CSIQ shows 648.42% growth. Joel Greenblatt would examine position.
-59.47%
Operating margin decline while CSIQ shows 304.37% growth. Joel Greenblatt would examine position.
-366.81%
Other expenses reduction while CSIQ shows 84.84% growth. Joel Greenblatt would examine advantage.
-172.02%
Pre-tax income decline while CSIQ shows 5533.19% growth. Joel Greenblatt would examine position.
-128.07%
Pre-tax margin decline while CSIQ shows 2943.60% growth. Joel Greenblatt would examine position.
133.47%
Tax expense growth less than half of CSIQ's 635.04%. David Dodd would verify if advantage is sustainable.
-91.84%
Net income decline while CSIQ shows 933.05% growth. Joel Greenblatt would examine position.
-60.85%
Net margin decline while CSIQ shows 458.15% growth. Joel Greenblatt would examine position.
-89.47%
EPS decline while CSIQ shows 872.73% growth. Joel Greenblatt would examine position.
-89.47%
Diluted EPS decline while CSIQ shows 854.55% growth. Joel Greenblatt would examine position.
0.33%
Share count reduction exceeding 1.5x CSIQ's 8.69%. David Dodd would verify capital allocation.
0.33%
Diluted share reduction exceeding 1.5x CSIQ's 9.86%. David Dodd would verify capital allocation.